Planet Labs (PL) director sells 11,500 shares under Rule 10b5-1 plan

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Planet Labs PBC director Brennan Ita M reported an open-market sale of Class A Common Stock. On July 1, 2026, he sold 11,500 shares at a weighted average price of $32.9978 per share in multiple trades under a pre-arranged Rule 10b5-1 trading plan adopted on January 14, 2026. After this sale, he directly holds 252,658 shares of Class A Common Stock, including 32,468 RSUs that vest in full on the earlier of the first anniversary of grant or the issuer's next annual stockholder meeting.

Insider Trade Summary 10b5-1

Net Seller: 11,500 shares ($379,475)

Net Sell 1 txn

Insider Brennan Ita M

Role null

Sold 11,500 shs ($379K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	11,500	$32.9978	$379K

Holdings After Transaction: Class A Common Stock — 252,658 shares (Direct, null)

Footnotes (1)

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026. The sales were executed in multiple trades at prices ranging from $31.54 to $34.10. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Includes 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Key Figures

Shares sold: 11,500 shares Average sale price: $32.9978 per share Price range of sales: $31.54–$34.10 per share +2 more

5 metrics

Shares sold 11,500 shares Open-market sale on July 1, 2026

Average sale price $32.9978 per share Weighted average across multiple trades

Price range of sales $31.54–$34.10 per share Multiple trades on July 1, 2026

Shares held after transaction 252,658 shares Direct Class A Common Stock holdings post-sale

RSUs included in holdings 32,468 RSUs Vest on first anniversary of grant or next annual meeting

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, RSUs, contingent right, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported reflects the weighted average sale price"

RSUs financial

"Includes 32,468 RSUs which fully vest on the earlier of (i) the first anniversary"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

contingent right financial

"The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock"

Class A Common Stock financial

"The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:04 PM Accepted by SEC EDGAR 07/02/2026 - 04:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brennan Ita M

(Last)

(First)

(Middle)

C/O PLANET LABS PBC

645 HARRISON STREET, FLOOR 4

(Street)

SAN FRANCISCO

CALIFORNIA

94107

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Planet Labs PBC [ PL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	07/01/2026		S		11,500⁽¹⁾	D	$32.9978⁽²⁾	252,658⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.

2. The sales were executed in multiple trades at prices ranging from $31.54 to $34.10. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

3. Includes 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

	By: /s/ LeeAnn Linck, Attorney-in-fact for: Ita M Brennan	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Planet Labs (PL) disclose for Brennan Ita M?

Planet Labs disclosed that director Brennan Ita M sold 11,500 shares of Class A Common Stock. The transaction was an open-market sale executed on July 1, 2026, at a weighted average price of $32.9978 per share, executed in multiple trades.

Was the Planet Labs (PL) insider sale done under a Rule 10b5-1 plan?

Yes. The sale by Brennan Ita M was executed under a pre-arranged Rule 10b5-1 trading plan. This plan was adopted on January 14, 2026, meaning the trades were scheduled in advance rather than timed discretionarily with short-term market movements.

How many Planet Labs (PL) shares does Brennan Ita M hold after the sale?

Following the reported transaction, Brennan Ita M directly holds 252,658 shares of Planet Labs Class A Common Stock. This total includes restricted stock units that are scheduled to vest later, giving him continued equity exposure to Planet Labs after the sale.

What price range were the Planet Labs (PL) shares sold for in this Form 4?

The shares were sold in multiple trades with prices ranging from $31.54 to $34.10. The Form 4 reports a weighted average sale price of $32.9978 per share and notes full trade-by-trade details are available upon request to the company or regulators.

What RSUs does Brennan Ita M hold at Planet Labs (PL)?

Brennan Ita M holds 32,468 restricted stock units (RSUs) linked to Planet Labs Class A Common Stock. These RSUs fully vest on the earlier of the first anniversary of the grant date or the company’s next annual stockholder meeting, then settle one share per unit.

Is the Planet Labs (PL) insider transaction a market purchase or sale?

The reported Planet Labs insider transaction is a sale, not a purchase. It is classified as an open-market sale of 11,500 Class A Common Stock shares, coded as an “S” transaction on Form 4 and described as a sale in open market or private transactions.